Detalles de la búsqueda
1.
Serosurvey for Japanese encephalitis virus antibodies following an outbreak in an immunologically naïve population, Victoria, 2022: a cross-sectional study.
Med J Aust;
2024 May 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-38803004
2.
The seroprevalence of antibodies to Japanese encephalitis virus in five New South Wales towns at high risk of infection, 2022: a cross-sectional serosurvey.
Med J Aust;
2024 May 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38815982
3.
Assessing the effects of SARS-CoV-2 vaccination on the risk of household transmission during delta variant circulation: a population-based data linkage cohort study.
Lancet Reg Health West Pac;
42: 100930, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38357393
4.
Seroprevalence of Japanese encephalitis virus-specific antibodies in Australia following novel epidemic spread: protocol for a national cross-sectional study.
BMJ Open;
14(2): e075569, 2024 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38326269
5.
Effectiveness of bivalent COVID-19 boosters against COVID-19 mortality in people aged 65 years and older, Australia, November 2022 to May 2023.
Euro Surveill;
28(47)2023 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-37997663
6.
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccines.
Vaccine;
41(48): 7192-7200, 2023 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-37903679
7.
Effectiveness of COVID-19 vaccination against COVID-19 specific and all-cause mortality in older Australians: a population based study.
Lancet Reg Health West Pac;
40: 100928, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37854458
8.
Summary of National Surveillance Data on Vaccine Preventable Diseases in Australia, 2016-2018 Final Report.
Commun Dis Intell (2018);
472023 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37817298
9.
ATAGI 2023 Annual Statement on Immunisation.
Commun Dis Intell (2018);
472023 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-37817301
10.
Annual immunisation coverage report 2021.
Commun Dis Intell (2018);
472023 08 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-37817316
11.
Coverage and predictors of influenza and pertussis vaccination during pregnancy: a whole of population-based study.
Vaccine;
41(43): 6522-6529, 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37741762
12.
The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study.
Lancet Reg Health West Pac;
40: 100894, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37701717
13.
Erratum to "Real world impact of 13vPCV in preventing invasive pneumococcal pneumonia in Australian children: A national study" [Vaccine 41(1) (2023) 85-91].
Vaccine;
41(42): 6401-6402, 2023 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37625991
14.
Comparative effectiveness of four COVID-19 vaccines, BNT162b2 mRNA, mRNA-1273, ChAdOx1 nCov-19 and NVX-CoV2373 against SARS-CoV-2 B.1.1.529 (Omicron) infection.
Vaccine;
41(38): 5587-5591, 2023 08 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37524631
15.
Comparative B cell and antibody responses induced by adenoviral vectored and mRNA vaccines against COVID-19.
medRxiv;
2023 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37333329
16.
Corrigendum to "Lower risk of multi-system Inflammatory Syndrome in Children (MIS-C) with the Omicron variant" [The Lancet Regional Health - Western Pacific 27 (2022) 100604].
Lancet Reg Health West Pac;
35: 100808, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37274779
17.
Seroprevalence and prevention of hepatitis B, measles and rubella among healthcare workers in Dili, Timor-Leste.
Lancet Reg Health Southeast Asia;
13: 100133, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-37383559
18.
Short-term Adverse Events Following Immunization With Modified Vaccinia Ankara-Bavarian Nordic (MVA-BN) Vaccine for Mpox.
JAMA;
329(23): 2091-2094, 2023 06 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37145654
19.
Complex intervention to promote human papillomavirus (HPV) vaccine uptake in school settings: A cluster-randomized trial.
Prev Med;
172: 107542, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-37172767
20.
Vaccine Preventable Disease Seroprevalence in a Nationwide Assessment of Timor-Leste (VASINA-TL): study protocol for a population-representative cross-sectional serosurvey.
BMJ Open;
13(5): e071381, 2023 05 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37202138